Hematopoietic Stem Cell TransplantationStem Cell TransplantationStem CellsTransplantation, HomologousAdult Stem CellsHematopoietic Stem CellsEmbryonic Stem CellsTransplantation, AutologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationCell DifferentiationGraft vs Host DiseaseHematologic NeoplasmsBone Marrow TransplantationLiver TransplantationTransplantation ChimeraMesenchymal Stem Cell TransplantationTissue DonorsTreatment OutcomeCord Blood Stem Cell TransplantationGraft SurvivalMyeloablative AgonistsCell TransplantationKidney TransplantationWhole-Body IrradiationBusulfanHistocompatibility TestingRecurrenceMultiple MyelomaAntigens, CD34Combined Modality TherapyRemission InductionHematopoiesisLeukemiaHistocompatibilityRetrospective StudiesImmunosuppressive AgentsHematopoietic Stem Cell MobilizationMelphalanGraft vs Leukemia EffectBone Marrow CellsPluripotent Stem CellsHeart TransplantationVidarabineTime FactorsStem Cell NicheDisease-Free SurvivalTransplantation ImmunologyLeukemia, Myeloid, AcuteSurvival RateSurvival AnalysisLung TransplantationNeural Stem CellsChimerismMesenchymal Stromal CellsGraft RejectionCyclophosphamideGraft vs Tumor EffectAntineoplastic Combined Chemotherapy ProtocolsHepatic Veno-Occlusive DiseaseCell LineageSalvage TherapySiblingsInduced Pluripotent Stem CellsMyelodysplastic SyndromesHLA AntigensHematologic DiseasesOrgan TransplantationLymphocyte TransfusionCells, CulturedTransplantation, IsogeneicStem Cell FactorUnrelated DonorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantationMultipotent Stem CellsFollow-Up StudiesGranulocyte Colony-Stimulating FactorLymphoma, Non-HodgkinFlow CytometryPrecursor Cell Lymphoblastic Leukemia-LymphomaAntilymphocyte SerumBone MarrowImmunosuppressionIslets of Langerhans TransplantationHematopoietic SystemMice, Inbred C57BLFetal Stem CellsCytomegalovirus InfectionsLymphocyte DepletionAnemia, AplasticT-LymphocytesAcute DiseaseCytarabineHodgkin DiseaseLiving DonorsPrognosisFetal BloodCell ProliferationPancreas Transplantation